Gene · 100616443
Papers2,197
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,197
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Role of Non-Coding RNAs in the Regulation of Oncogenic Pathways in Breast and Gynaecological Cancers. | Noncoding RNA | 2025 | 40863727 | PubTator, text mining | PubMed |
| Reproducible Boolean model analyses and simulations with the CoLoMoTo software suite: a tutorial. | Interface Focus | 2025 | 40862235 | PubTator, text mining | PubMed |
| Mechanisms and therapeutics of insulin signaling transduction genes in diabetic cardiomyopathy: a comprehensive updated review. | Front Endocrinol (Lausanne) | 2025 | 40747301 | PubTator, text mining | PubMed |
| PI3K/AKT/mTOR Axis in Cancer: From Pathogenesis to Treatment. | MedComm (2020) | 2025 | 40740483 | PubTator, text mining | PubMed |
| Cancer-Associated PIK3R1 Genetic Aberrations and Precision Medicine. | Int J Med Sci | 2025 | 40657399 | PubTator, text mining | PubMed |
| Targeting the RARα-Gankyrin-PI3K axis with retinoid analogs to modulate autophagy in breast cancer cells: Computational insights and experimental validation. | Comput Biol Chem | 2025 | 40582253 | PubTator, text mining | PubMed |
| Safety overview and management of inavolisib alone and in combination therapies in PIK3CA-mutated, HR-positive, HER2-negative advanced breast cancer (GO39374). | ESMO Open | 2025 | 40513140 | PubTator, text mining | PubMed |
| The central signaling pathways related to metabolism-regulating hormones of the gut-brain axis: a review. | J Transl Med | 2025 | 40500780 | PubTator, text mining | PubMed |
| Tyrosine kinase inhibitors induce cardiotoxicity by causing Ca2+ overload through the inhibition of phosphoinositide 3-kinase activity. | Biochem Biophys Res Commun | 2025 | 40403685 | PubTator, text mining | PubMed |
| RPUSD1 enhances the expression of eIF4E through RluA catalytic domain, activates PI3K/AKT signaling pathway, and promotes the cell proliferation and invasion in non-small cell lung cancer. | Int J Biol Macromol | 2025 | 40010477 | PubTator, text mining | PubMed |
| mRNA Transcript Variants Expressed in Mammalian Cells. | Int J Mol Sci | 2025 | 39940824 | PubTator, text mining | PubMed |
| Oncogenic activation of PI K3 CA in cancers: Emerging targeted therapies in precision oncology. | Genes Dis | 2025 | 39717717 | PubTator, text mining | PubMed |
| MVGNet: Prediction of PI3K Inhibitors Using Multitask Learning and Multiview Frameworks. | ACS Omega | 2024 | 39554430 | PubTator, text mining | PubMed |
| Immunometabolism: signaling pathways, homeostasis, and therapeutic targets. | MedComm (2020) | 2024 | 39492834 | PubTator, text mining | PubMed |
| Building multiscale models with PhysiBoSS, an agent-based modeling tool. | Brief Bioinform | 2024 | 39425527 | PubTator, text mining | PubMed |
| Unveiling the role of PIK3R1 in cancer: A comprehensive review of regulatory signaling and therapeutic implications. | Semin Cancer Biol | 2024 | 39197810 | PubTator, text mining | PubMed |
| Building multiscale models with PhysiBoSS, an agent-based modeling tool. | ArXiv | 2024 | 38979487 | PubTator, text mining | PubMed |
| PI3K/AKT signaling alters glucose metabolism in uterine microenvironment of women with idiopathic recurrent spontaneous miscarriage. | Clin Chim Acta | 2024 | 38944409 | PubTator, text mining | PubMed |
| Chemotherapy-induced high expression of IL23A enhances efficacy of anti-PD-1 therapy in TNBC by co-activating the PI3K-AKT signaling pathway of CTLs. | Sci Rep | 2024 | 38902343 | PubTator, text mining | PubMed |
| PIK3IP1: structure, aberration, function, and regulation in diseases. | Eur J Pharmacol | 2024 | 38897445 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/100616443/papers?page=2